Vitamin K and direct oral anticoagulants in patients with major bleeding: Risk assessment.
Department of Hygiene and Public Health, Nippon Medical School, 1-1-5 Sendagi, Bunkyo-Ku, Tokyo 113-8602, Japan.
Tomoyuki
T
Kawada
D000284:Administration, Oral; D000925:Anticoagulants; D006470:Hemorrhage; D006801:Humans; D018570:Risk Assessment; D014812:Vitamin K
D000925:Anticoagulants; D014812:Vitamin K
Direct oral anticoagulants; Intracranial hemorrhage; Major bleeding; Mortality; Vitamin K anticoagulants